University of Health Sciences (UHS) Lahore receives a 3-year license from the Drug Regulatory Authority of Pakistan (DRAP) to test the coronavirus vaccine as a test trail.
The UHS received this license so that it could be used as a site for the phase-III clinical trial of a Chinese vaccine. The permission included a trial of the vaccine on humans for three years.
On August 10 this year, DRAP sought an explanation from the vice-chancellor of the university for initiating clinical trials of a potential coronavirus vaccine without prior approval.
According to sources, DRAP issued a show-cause notice to Prof Dr. Javed Akram to explain his position in this regard.
DRAP cleared that it has not approved any clinical trials and that clinical study without its approval breach Clinical Trial Bio-Study Rules 2017.
The source information, DRAP asked the UHS to immediately stop the clinical study of vaccines and explain why the university started clinical trials without approval from the drug regulator.